CoagulationDisorders near Jamaica, NY

Care Philosophy: Our lymphoma group practice provides specialized and multidisciplinary care in the setting of a leading medical institution for patients with all types of lymphomas. We strive to deliver the best possible standard of care, and take pride in our comprehensive clinical research program that provides access to state-of-the-art novel agents and combination treatments that continue to transform care for lymphoma patients, often years before they become widely available elsewhere. With a research background in tumor immunology and vascular medicine, my clinical research has been focused on developing new immunotherapy-based treatments that target the tumor microenvironment for a variety of lymphoma subtypes, including rare diseases such as mantle cell lymphoma and T-cell lymphoma. Another focus of mine is to develop low-intensity biologic-based treatments that minimize side effects and maximize quality-of-life. I believe in personalized, compassionate, and informed care that is tailored to each individual patient's needs.

Care Philosophy: My main goal as an oncologist is to improve the quality and the duration of life of my patients and, all through their treatment, to develop an environment of compassion and mutual trust. Research in oncology is crucial for improving the prognosis of cancer patients and I have a strong passion for clinical and translational research. Each person is different and I am constantly striving to provide my patients the best personalized oncology care currently available for his or her specific condition. Additionally, I am committed to integrating innovative and more performant diagnostic and treatment methods within my practice.

Biography: Jones Nauseef, M.D., Ph.D., is an Assistant Professor of Medicine within the Division of Hematology and Medical Oncology at Weill Cornell Medicine, and Assistant Attending physician at NewYork-Presbyterian Hospital. His clinical emphasis is on Genitourinary (GU) cancers and Phase I clinical trials. His research is focused on genomics of advanced prostate cancers, including neuroendocrine prostate cancer, as well as health care disparities.Dr. Nauseef received his B.A. in Biology in 2006 from Swarthmore College, where he also participated in NCAA Track and Cross Country. In 2015, Dr. Nauseef earned his M.D. and Ph.D. in Molecular Physiology and Biophysics (Laboratory of Dr. Michael D. Henry) as part of the NIH-sponsored MedicalScientist Training Program (MSTP) at the Carver College of Medicine of theUniversity of Iowa. He continued his medical training at Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP), where he completed his Internship and Residency in Internal Medicine in 2018. He was honored to be the recipient of the David B. Skinner award at the conclusion of his residency. He remained at WCM/NYP for his Fellowship in Hematology and Medical Oncology, during which time he was awarded a 2020 Conquer Cancer Foundation of ASCO Young Investigator Award (YIA) and the 2021 Scott Wadler Fellows Clinical Research Award. During his Fellowship, Dr. Nauseef expanded his research focus to include the genomics of advanced prostate cancers and health care disparities in American men of African descent. He serves as co-investigator or collaborator on extramural grants for the latter project. Dr. Nauseef will continue these investigations as a member of the Englander Institute for Precision Medicine and inaffiliation with the New York Genome Center, with the primary goal of leveraging discoveries to develop clinical trials as part of the Phase I/Earlytherapeutics group at Weill Cornell's Meyer Cancer Center.

Biography: Dr. Matthew Galsky, MD is a Hematology Specialist who practices in New York, NY. He is 53 years old and has been practicing for 27 years. Dr. Matthew Galsky, MD is affiliated with Mount Sinai Hospital.